Results 161 to 170 of about 7,229 (203)
Some of the next articles are maybe not open access.
Boceprevir, telaprevir, and rilpivirine hydrochloride
Journal of the American Pharmacists Association, 2012Antiviral agents Agents for hepatitis C virus infection Hepatitis C virus (HCV) infection is characterized by inflammation of the liver, which can lead to reduced liver function and liver failure. The infection can develop in a number of ways, including exposure to blood that is infected with the virus, being born to a mother with HCV, having a sexual ...
Daniel A, Hussar, Clayton W, Snell
openaire +2 more sources
Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland [PDF]
Lancet Regional Health - Europe, TheBACKGROUND: The efficacy and tolerability of long-acting cabotegravir and rilpivirine were demonstrated in Phase III trials. However, low concentrations combined with other risk factors have been associated with an increased risk of virologic failure ...
François R Girardin +2 more
exaly +3 more sources
[Resistance profile of rilpivirine].
Enfermedades infecciosas y microbiologia clinica, 2015Rilpivirine (RPV) is a new second-generation nonnucleoside reverse transcriptase inhibitor (NNRTI) approved for use in combination with two nucleoside/nucleotide reverse transcriptase inhibitors (NRTI) as initial therapy in treatment-naïve HIV-1-infected patients with a baseline viral load ≤100,000 copies/mL.
Arkaitz, Imaz +3 more
openaire +2 more sources
Cabotegravir/Rilpivirine: the last FDA-approved drug to treat HIV
Expert Review of Anti-Infective Therapy, 2022Elahe Taki, Mohsen Heidary, Arezoo asadi
exaly